Cp2d
Generic Name: cp2d
Brand Names:
Cp2d
Description section ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION (CP2D), 250 mL 0455A-00 Description
Overview
Description section ANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE SOLUTION (CP2D), 250 mL 0455A-00 Description
Warnings
Warnings and precautions Warnings Not for direct intravenous infusion. Single-use container – discard unused portion. (do not reuse) Do not use unless the solution is clear and no leaks are detected. Precautions Use only with automated red-cell apheresis devices and follow the Operator’s Manual. Refer to the package insert for complete instructions. Storage/handling: Store at 25 °C/77 °F, avoid excessive heat, protect from freezing. Pouch is a moisture barrier; handle to maintain package integrity. Warnings and precautions
Storage
Storage and handling section Store at room temperature (25 °C/77 °F). Avoid excessive heat. Protect from freezing. Storage and handling
Frequently Asked Questions
What are the important warnings for Cp2d?▼
Warnings and precautions Warnings Not for direct intravenous infusion. Single-use container – discard unused portion. (do not reuse) Do not use unless the solution is clear and no leaks are detected. Precautions Use only with automated red-cell apheresis devices and follow the Operator’s Manual. Refer to the package insert for complete instructions. Storage/handling: Store at 25 °C/77 °F, avoid excessive heat, protect from freezing. Pouch is a moisture barrier; handle to maintain package integrity. Warnings and precautions
Related Medications
Empagliflozin (process Ii)
empagliflozin (process ii)
Dosage form: POWDER. Active ingredients: EMPAGLIFLOZIN (1 kg/kg). Category: BULK INGREDIENT.
Ropivacaine Hcl
ropivacaine hcl
Dosage form: POWDER. Active ingredients: ROPIVACAINE HYDROCHLORIDE (1 kg/kg). Category: BULK INGREDIENT.
Sunvozertinib
sunvozertinib
Manufactured by DIZAL JIANGSU. Dosage form: TABLET. Route: ORAL. Active ingredients: SUNVOZERTINIB (150MG). Application: NDA219839.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.